Clinical Trial Update: Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396) [Phase 4]

View source ↗

Summary

A Phase 4 post-marketing trial evaluating Montelukast in combination with Theophylline added to inhaled corticosteroids for asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Montelukast)
• Theophylline (Theophylline)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 4 | Status: COMPLETED